Publications by authors named "C Y Chain"
Article Synopsis
- Gaucher Disease (GD) is a genetic condition caused by a deficiency in the enzyme glucocerebrosidase, and Velaglucerase alfa is used to replace this enzyme through therapy.
- Novel nanoparticle systems made from Eudragit have been developed to enhance the delivery and effectiveness of Velaglucerase alfa, demonstrating high stability and efficient encapsulation.
- In laboratory studies, these nanoparticles showed improved interaction with important proteins, better enzyme release in acidic conditions, and increased internalization in GD cells, leading to enhanced enzyme activity without affecting cell viability.
Pseudomonas aeruginosa is a leading cause of hospital-acquired infections for which the development of antibiotics is urgently needed. Unlike most enteric bacteria, P. aeruginosa lacks enzymes required to scavenge exogenous thymine.
View Article and Find Full Text PDFPlant and herbal essential oils (EOs) offer a wide range of pharmacological actions that include anticancer effects. Here, we evaluated the cytotoxic activity of EO from (chemotype linalool), (chemotype dihydrocarvone, LaDEO), (L.) (CnEO), , × , × , L.
View Article and Find Full Text PDFChagas disease is a neglected endemic disease prevalent in Latin American countries, affecting around 8 million people. The first-line treatment, benznidazole (BNZ), is effective in the acute stage of the disease but has limited efficacy in the chronic stage, possibly because current treatment regimens do not eradicate transiently dormant amastigotes. Nanostructured lipid carriers (NLC) appear to be a promising approach for delivering pharmaceutical active ingredients as they can have a positive impact on bioavailability by modifying the absorption, distribution, and elimination of the drug.
View Article and Find Full Text PDFArticle Synopsis
- * Researchers developed lipid-based nanoparticles, specifically nanostructured lipid carriers (NLCs), to enhance drug delivery and improve permeability of the antiepileptic drug phenobarbital without causing toxicity.
- * The optimized NLCs were characterized by favorable properties like size (~178 nm) and high entrapment efficiency (98.2%), and showed prolonged drug release and non-toxic effects in tests, indicating potential effectiveness in treating seizures.